180 related articles for article (PubMed ID: 26199254)
1. [Leukostasis during Chronic Myelogenous Leukemia Resolved Following Leukapheresis].
Yoshida M; Ueda H; Imaizumi J; Horiuchi M; Hagihara K; Kanashima H; Nakao T; Azuma K; Itoi J; Yamane T
Gan To Kagaku Ryoho; 2015 Jun; 42(6):763-5. PubMed ID: 26199254
[TBL] [Abstract][Full Text] [Related]
2. Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis.
Leis JF; Primack SL; Schubach SE; Curtin PT; Druker BJ; Maziarz RT
Haematologica; 2004 Sep; 89(9):ECR30. PubMed ID: 15377482
[TBL] [Abstract][Full Text] [Related]
3. [Leukapheresis in children with chronic myeloid leukemia and pulmonary leukostasis].
Bubała H; Sońta-Jakimczyk D; Janik-Moszant A; Szczepański T; Tomaszewska R; Drybańska B; Sierantowicz-Zdaniewicz U; Frankiewicz E
Pol Merkur Lekarski; 2004 Nov; 17(101):500-2. PubMed ID: 15754643
[TBL] [Abstract][Full Text] [Related]
4. Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature.
Chen B; Yan X; Zhang X; Yang H
Indian J Ophthalmol; 2018 Dec; 66(12):1871-1874. PubMed ID: 30451209
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
[TBL] [Abstract][Full Text] [Related]
6. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
Fujisawa S; Yano K; Kobayashi M
Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
[TBL] [Abstract][Full Text] [Related]
7. Leukocytosis: the mysteries within.
Munoz J; Guo Y
Am J Hematol; 2012 Feb; 87(2):197. PubMed ID: 21815181
[No Abstract] [Full Text] [Related]
8. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.
Shafique S; Bona R; Kaplan AA
Ther Apher Dial; 2007 Apr; 11(2):146-9. PubMed ID: 17381536
[TBL] [Abstract][Full Text] [Related]
9. [Case of pediatric chronic myeloid leukemia with bilateral visual loss onset].
Hara Y; Kamura Y; Oikawa A; Shichino H; Mugishima H; Goto H
Nippon Ganka Gakkai Zasshi; 2010 May; 114(5):459-63. PubMed ID: 20545220
[TBL] [Abstract][Full Text] [Related]
10. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: a retrospective analysis.
Thota NK; Gundeti S; Linga VG; Coca P; Tara RP;
Indian J Cancer; 2014; 51(1):5-9. PubMed ID: 24947087
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
[TBL] [Abstract][Full Text] [Related]
13. CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN BLAST CRISIS.
Sarwar S; Siddiqui N; Zafar W; Fasih S; Basit A; Hameed A
J Ayub Med Coll Abbottabad; 2015; 27(2):371-4. PubMed ID: 26411119
[TBL] [Abstract][Full Text] [Related]
14. [Standard therapy for chronic myelogenous leukemia].
Kimura S
Rinsho Ketsueki; 2012 Oct; 53(10):1571-80. PubMed ID: 23037729
[No Abstract] [Full Text] [Related]
15. Persistence of molecular remission throughout pregnancy in CML after imatinib.
Sorà F; De Matteis S; Bajer J; D'alò F; Leone G; Sica S
Leuk Res; 2009 Jun; 33(6):e6-7. PubMed ID: 18937976
[No Abstract] [Full Text] [Related]
16. Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.
Moser O; Krumbholz M; Thiede C; Tauer JT; Janz I; Lauten M; Dilloo D; Metzler M; Suttorp M
Pediatr Blood Cancer; 2014 Nov; 61(11):2080-2. PubMed ID: 24810322
[TBL] [Abstract][Full Text] [Related]
17. Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.
Skalska-Sadowska J; Januszkiewicz-Lewandowska D; Derwich K; Pieczonka A; Samborska M; Wachowiak J
Pediatr Blood Cancer; 2015 Jun; 62(6):1070-1. PubMed ID: 25631405
[TBL] [Abstract][Full Text] [Related]
18. Imatinib or transplant for chronic myeloid leukaemia?
Craddock C; Augustson B; Basu S
Lancet; 2003 Jul; 362(9378):173. PubMed ID: 12867130
[No Abstract] [Full Text] [Related]
19. Imatinib or transplant for chronic myeloid leukaemia?
Goldman J; Apperley J; Kanfer E; Olavarria E; Marin D
Lancet; 2003 Jul; 362(9378):172-3. PubMed ID: 12867128
[No Abstract] [Full Text] [Related]
20. Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.
Savani BN; Srinivasan R; Espinoza-Delgado I; Dorrance C; Takahashi Y; Igarashi T; Rezvani K; Lundqvist A; Barrett AJ; Childs RW
Lancet Oncol; 2005 Oct; 6(10):809-12. PubMed ID: 16198987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
